戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 al resolution of MRI with the sensitivity of radionuclide imaging.
2 ercise and psychological stress testing with radionuclide imaging.
3 on late after reflow was similar for MCE and radionuclide imaging.
4  do not have myocardial perfusion defects on radionuclide imaging.
5 bits were killed, and the testes excised for radionuclide imaging.
6 s detected in 85% of torsed testes at US and radionuclide imaging.
7 with color Doppler US, power Doppler US, and radionuclide imaging.
8  includes lab tests, ultrasound imaging, and radionuclide imaging.
9 and retention of the new cationic lipophilic radionuclide imaging agent 99mTc-Q12 are currently unkno
10 s in vitro, with technetium-99m (99mTc) as a radionuclide imaging agent that can localize and non-inv
11 istributions of gamma- (and x-) ray-emitting radionuclide imaging agents or therapeutics.
12 he functional tumor characteristics shown by radionuclide imaging allow for more accurate staging and
13  spinal cord injuries using a combination of radionuclide imaging and clearance measurement.
14 was correctly diagnosed in 25% of cases with radionuclide imaging and in 60% of cases with US.
15 n human medical imaging, with an emphasis on radionuclide imaging and MRI.
16                                         Both radionuclide imaging and near-infrared fluorescent (NIRF
17 feasibility of using anti-PD-L1 antibody for radionuclide imaging and radioimmunotherapy and highligh
18 )}(2) a promising agent for peptide receptor radionuclide imaging and therapy of integrin-positive tu
19 toma expresses several molecular targets for radionuclide imaging and therapy, of which the most wide
20 ed as a possible target for peptide receptor radionuclide imaging and therapy.
21 ity of the 2009 Appropriate Use Criteria for radionuclide imaging and whether physicians at various l
22  who were referred for exercise testing with radionuclide imaging, and 21 healthy volunteers, were en
23  noninvasive imaging using echocardiography, radionuclide imaging, and cardiac magnetic resonance enh
24 ography, small-bowel transit measurements by radionuclide imaging, and enteroscopy.
25                   Our method enables on-chip radionuclide imaging by incorporating an inorganic scint
26               Finally, the visual quality of radionuclide imaging can be improved with corrections fo
27                                              Radionuclide imaging can be particularly useful if MR im
28  Guidelines recommend 3-hour cardiac amyloid radionuclide imaging (CARI) for transthyretin amyloid ca
29 d chest radiograph, computed tomogram scans, radionuclide imaging, diagnostic cardiac catheterization
30 a noninvasive fashion using current clinical radionuclide imaging equipment.
31 w and regional metabolism can be assessed by radionuclide imaging, especially SPECT and PET.
32 c considerations in breast cancer and covers radionuclide imaging for detection and staging.
33  considerations in breast cancer and covered radionuclide imaging for detection and staging.
34                                  Noninvasive radionuclide imaging has the potential to identify and a
35 response to etanercept could be monitored by radionuclide imaging in arthritic mice.
36              The role of echocardiography or radionuclide imaging in the management and monitoring of
37 tions (ASNC I2) series to assess the role of radionuclide imaging in the multimodality context for th
38 f NIS expression is sufficient to facilitate radionuclide imaging in vivo.
39 ted alterations of molecular phenotype using radionuclide imaging is a noninvasive approach to strati
40 ty for the 2009 Appropriate Use Criteria for radionuclide imaging is modest, and there is considerabl
41                                  Noninvasive radionuclide imaging is well suited to dynamically track
42                                              Radionuclide imaging methods are emerging as a highly sp
43              Other cardiac imaging for which radionuclide imaging might be substituted was similarly
44 n in vivo has been well studied by using the radionuclide imaging modalities in various preclinical t
45                            Part 2 will cover radionuclide imaging of breast cancer response to therap
46                                Part 2 covers radionuclide imaging of breast cancer response to therap
47                                              Radionuclide imaging of cancer-associated molecular alte
48         This review addresses recent work on radionuclide imaging of cardiovascular inflammation, inf
49 y was to evaluate the feasibility of in vivo radionuclide imaging of IGF-1R expression in prostate ca
50                                              Radionuclide imaging of IGF-1R in tumors might be used f
51                                  Noninvasive radionuclide imaging of inflammation is feasible by MCP-
52                                              Radionuclide imaging of myocardial perfusion, function,
53 e resulted in rapid integration of molecular radionuclide imaging of pancreatic neoplasms into mainst
54 y was to evaluate the feasibility of in vivo radionuclide imaging of PDGFRbeta expression using an Af
55 strate, for the first time, fluorescence and radionuclide imaging of sialylated glycans in a murine t
56 verity of inflammation were also assessed by radionuclide imaging of the neutrophil-avid tracer 99mTc
57 cted using a realistic physical model of the radionuclide imaging process including nonideal collimat
58 volume errors by mathematically modeling the radionuclide imaging process.
59 Appropriate Use Criteria (AUC) published for radionuclide imaging (RNI), stress echocardiography (Ech
60  a scintillating balloon-enabled fiber-optic radionuclide imaging (SBRI) system to improve the sensit
61                                     External radionuclide imaging showed a two- to sixfold increase i
62                                   Presently, radionuclide imaging such as PET and SPECT is not used i
63    Tracking ex vivo radiolabeled cells using radionuclide imaging such as positron emission tomograph
64                             Breast-dedicated radionuclide imaging systems show promise for increasing
65                                              Radionuclide imaging techniques are both useful and reli
66                To evaluate the usefulness of radionuclide imaging techniques for presurgical evaluati
67 limitations of broad clinical application of radionuclide imaging, this technology has a great impact
68                                              Radionuclide imaging using single photon emission comput
69                                              Radionuclide imaging was performed immediately after int
70 ow reductions of > or =50% not identified by radionuclide imaging were apparent in MRFP full-thicknes
71            This is a unique selling point of radionuclide imaging, which has been underrecognized in
72                                              Radionuclide imaging with 18F-fluorodeoxyglucose (FDG) p
73                                              Radionuclide imaging with [(18)F]BF4(-) (PET/CT) was com
74                    ATTR-CA was determined by radionuclide imaging, with blood testing to exclude ligh
75 cal approach for integrating high-resolution radionuclide imaging within standard microfluidics devic